Please login to the form below
clinical trials
This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.
Akcea steals march on Alnylam with NICE approval
This is vital for Tegsedi, which had generally been seen as the runner-up to Onpattro in terms of the data produced in their pivotal clinical trials.
Latest news
-
CAR-T player Autolus seeks $100m from follow-on financing
proceeds of around $94m and its existing cash mainly for trials of its lead candidates and to build up its manufacturing capacity. ... Part of the funding block will also go on completing the proof-of-concept phases of its phase 1/2 clinical trials of
-
Roche says ‘discovery proteomics’ is heading for clinical trials
Proteomics was one technology name-checked by outgoing FDA Commissioner Scott Gottlieb in a recent statement admonishing the pharma industry for not adopting innovative approaches to clinical trials. ... The approach could support the design of more
-
Sanofi exits R&D pact with Alnylam on rare disease
Alnylam is preparing that for clinical testing, and if Sanofi exercises its option it will be responsible for any future development and commercialisation, paying royalties to Alnylam if approved. ... The clinical hold was lifted a few weeks later however
-
Success for AZ, setback for Sanofi in type 1 diabetes
Both AZ and Sanofi/Lexicon’s drugs have been shown in clinical trials to achieve a significant and clinically-meaningful reductions from baseline in average blood glucose levels compared to insulin ... agency is also concerned that DKA may be hard to
-
Novo uses voucher for speedy answer on oral semaglutide
Novo's submission for oral semaglutide for the treatment of glycaemic control in adults with type 2 diabetes is based on the results from 10 Pioneer clinical trials, which included more ... The FDA, which will make a decision by September, will review
More from news
Approximately 159 fully matching, plus 1,570 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement. In 2014, the European Medicines Agency (EMA) gave the first indication that layperson summaries of the results of pharma-sponsored clinical trials ... This was part of a drive towards
-
Vertex: a vision of treating all CF patients worldwide draws closer
These include alpha-1 antitrypsin deficiency and focal segmental glomerulosclerosis. It’s also working with CRISPR Therapeutics on phase 1/2 clinical trials for CTX001, a gene editing therapy for patients
-
Brain power: fresh approaches to Alzheimer’s drug discovery
Two further candidates, AL003 for Alzheimer’s disease and AL004 for multiple degenerative disorders, are also set to enter clinical trials this year. ... Adaptive clinical trials dispense with the classical placebo-controlled design, and instead tests
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties? ... James Brook is head of UK and Ireland clinical delivery at IQVIA, one of the biggest contract research investors in
-
Combining therapies and combining research
Helperby is identified by WHO as a company with candidate therapies in clinical trial stage that are capable of fighting all three Critical Priority Pathogens. ... working in the AMR field and more investment for clinical trials.
More from intelligence
Approximately 11 fully matching, plus 151 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics.
-
Zelluna Immunotherapy appoints chief technology officer
His experience, acquired on both side’s of the Atlantic will provide invaluable for Zelluna in its immediate focus of delivering clinical proof of concept of its TCRs in adoptive cell ... He will play a big part in the execution of Zelluna’s
-
Neurocentrx appoints two members to the board
Brooksby said: “My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market.
-
Life Healthcare appoints two new starters
Joining Alisha is Caitlin McMaster (pictured right), who takes up an account executive role at Life Healthcare, working alongside the clinical trials team.
-
Topas Therapeutics appoints chief development officer and chief medical officer
Timm Jessen, chief executive officer, Topas, said: “Rupert has a long and successful track record of bringing drugs and biologics through clinical development and regulatory approval. ... At Topas, Dr. Sandbrink will guide projects into the clinic,
More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.
Latest from PMHub
-
Clinical Trials Materials: Getting the Basics Right
For those unfamiliar with them, clinical trials can be rather bewildering. ... Click here to download a copy and learn about removing some of the mystery around clinical trials.
-
Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis
This is often due to the lack of knowledge about the diseases and the high costs of running clinical trials and manufacturing drugs for a relatively small number of patients.
-
Artificial Intelligence in Healthcare
Presently, the looming Brexit saga is casting shadows over the UK’s ability to play host to clinical trials at the frontiers of medical innovation. ... But, with a joined-up digital healthcare system, robust clinical data sets, and the help of AI, why
-
Practical Patient Centricity
Most patients just want to be better – mode of action, robust clinical trials and health economic models are not relevant to them (but are to payers and HCPs). ... Cost effective wearable technology can gather this data, enabling the ‘silent patient
-
Insights from the charity sector – from patient engagement to people-driven design
But if engagement is merely a matter of involving them in clinical trials, advisory boards, focus groups or online forums, then we are missing out on great potential for even better
More from PMHub
Approximately 16 fully matching, plus 77 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Competitive salary and benefits
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
-
Director – Healthcare PR
-
Salary TBC
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
